Literature DB >> 27296784

Analysis of a model of gambiense sleeping sickness in humans and cattle.

A M Ndondo1, J M W Munganga2, J N Mwambakana3, C M Saad-Roy4, P van den Driessche4, R O Walo1.   

Abstract

Human African Trypanosomiasis (HAT) and Nagana in cattle, commonly called sleeping sickness, is caused by trypanosome protozoa transmitted by bites of infected tsetse flies. We present a deterministic model for the transmission of HAT caused by Trypanosoma brucei gambiense between human hosts, cattle hosts and tsetse flies. The model takes into account the growth of the tsetse fly, from its larval stage to the adult stage. Disease in the tsetse fly population is modeled by three compartments, and both the human and cattle populations are modeled by four compartments incorporating the two stages of HAT. We provide a rigorous derivation of the basic reproduction number R0. For R0 < 1, the disease free equilibrium is globally asymptotically stable, thus HAT dies out; whereas (assuming no return to susceptibility) for R0 >1, HAT persists. Elasticity indices for R0 with respect to different parameters are calculated with baseline parameter values appropriate for HAT in West Africa; indicating parameters that are important for control strategies to bring R0 below 1. Numerical simulations with R0 > 1 show values for the infected populations at the endemic equilibrium, and indicate that with certain parameter values, HAT could not persist in the human population in the absence of cattle.

Entities:  

Keywords:  34D23; 92D30; Trypanosoma brucei gambiense; elasticity; global stability; sleeping sickness; vector-borne disease

Mesh:

Year:  2016        PMID: 27296784     DOI: 10.1080/17513758.2016.1190873

Source DB:  PubMed          Journal:  J Biol Dyn        ISSN: 1751-3758            Impact factor:   2.179


  1 in total

1.  Analysis, modeling and optimal control of COVID-19 outbreak with three forms of infection in Democratic Republic of the Congo.

Authors:  A M Ndondo; S K Kasereka; S F Bisuta; K Kyamakya; E F G Doungmo; R-B M Ngoie
Journal:  Results Phys       Date:  2021-03-27       Impact factor: 4.476

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.